About
Regenyx Medical is redefining minimally invasive soft tissue restoration—a cornerstone of plastic and reconstructive surgery. Our lead product, Lipogenyx, is the first fat viability extender: a next-generation fat grafting solution that enhances graft survival and integration, enabling natural-looking, lasting and predictable results in reconstructive and aesthetic procedures. Built on a proprietary synthetic peptide hydrogel technology, Lipogenyx offers a scalable, potentially reimbursable platform that eliminates the need to revision fat grafting procedures and streamlines physicians efficiency and patient satisfaction. Selected for the 2025 MedTech Innovator and ASPS Top 5 Innovation Track, Regenyx is now preparing for its first clinical study and establishing U.S. operations.
Funding history · 3 rounds · $3.4M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Regenyx Medical's primary focus?
- Regenyx Medical is focused on redefining minimally invasive soft tissue restoration, particularly with its lead product, Lipogenyx, a fat viability extender for fat grafting procedures.
- When was Regenyx Medical founded?
- Regenyx Medical was founded in November 2016.
- What is Lipogenyx and its purpose?
- Lipogenyx is Regenyx Medical's lead product, a next-generation fat grafting solution designed to enhance graft survival and integration, aiming for lasting and predictable results in reconstructive and aesthetic procedures.
- What technology is Lipogenyx built upon?
- Lipogenyx is built on Regenyx Medical's proprietary synthetic peptide hydrogel technology.
- What is the current product stage for Regenyx Medical?
- Regenyx Medical's product, Lipogenyx, is currently in the clinical trial stage, with the company preparing for its first clinical study.
- What was Regenyx Medical's total funding raised as of the last reported round?
- Regenyx Medical has raised a total of $3,400,000 across multiple seed rounds. For full financing history, users can refer to startupim.
- When did Regenyx Medical complete its most recent funding round and for what amount?
- Regenyx Medical completed a Seed funding round in July 2023, raising $1,400,000.
- Which organization was a lead investor in Regenyx Medical's May 2019 Seed round?
- In May 2019, the Israel Innovation Authority was a lead investor in Regenyx Medical's Seed funding round.
- What recognition did Regenyx Medical receive in 2025?
- Regenyx Medical was selected for the 2025 MedTech Innovator and the ASPS Top 5 Innovation Track.
- What is Regenyx Medical's employee count?
- Regenyx Medical has 6 employees.